Skip to main content
. Author manuscript; available in PMC: 2010 Sep 21.
Published in final edited form as: Thromb Haemost. 2010 Apr 29;104(2):207–212. doi: 10.1160/TH09-10-0693

Table 1.

VTE Risk Factor Levels by Total TFPI Quartiles, LITE

Quartiles (Controls Only)
p for trend
1 2 3 4
N 262 271 265 237
TFPI (ng/mL, range) 22.3 (7.1, 27.4) 30.9 (27.5, 34.0) 37.5 (34.1, 41.9) 51 (42.0, 91.5)
Demographics
Age (years, SD) 59.9 (9.9) 62.2 (10.1) 63.6 (9.8) 64.0 (9.9) <0.001
Black Race (n, %)* 94 (25) 110 (29) 96 (26) 100 (27) 0.56
Female Sex (n, %)* 246 (66) 200 (54) 198 (53) 197 (53) 0.003
Physiologic Characteristics
BMI (SD) 27.3 (4.9) 28.0 (4.9) 28.6 (6.0) 27.9 (5.1) 0.05
Diabetes (n, %)* 30 (8) 43 (12) 63 (17) 60 (16) 0.01
Coronary Heart Disease (n, %) 16 (4) 42 (11) 37 (10) 33 (9) 0.004
Genetic Risk Factors
Factor V Leiden (n, %)* 21 (6) 17 (5) 20 (6) 15 (4) 0.71
Prothrombin 20210A (n, %)* 8 (2) 9 (2) 7 (2) 10 (3) 0.89
Biomarkers
Factor VII (%, SD) 120 (30) 116 (27) 123 (29) 125 (28) <0.001
Factor VIII (%, SD) 124 (36) 131 (38) 135 (43) 138 (47) <0.001
Factor IX (%, SD) 136 (31) 141 (30) 147 (31) 155 (31) <0.001
Factor XI (% SD) 126 (32) 128 (33) 135 (35) 144 (34) <0.001
D-dimer (ug/mL, SD) 0.51 (0.53) 0.51 (0.43) 0.61 (0.53) 0.65 (0.58) <0.001
*

p-value for χ2 test, other p-values from ANOVA